B. Riley Securities initiated coverage on Ovid Therapeutics with a new price target

4/30/24 8:03:00 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

B. Riley Securities initiated coverage of Ovid Therapeutics with a rating of Buy and set a new price target of $9.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$OVID

Date	Price Target	Rating	Analyst
6/18/2024		Outperform → Perform	Oppenheimer
4/30/2024	$9.00	Buy	B. Riley Securities
4/29/2024	$9.00	Buy	H.C. Wainwright
4/5/2024	$8.00	Outperform	Wedbush
12/21/2023	$11.00	Buy	BTIG Research
10/13/2023	$8.00	Outperform	Oppenheimer
8/25/2021	$4.50 → $4.00	Neutral	Citigroup